Generate Biomedicines
About Generate Biomedicines
Generate Biomedicines is a therapeutics company at the intersection of biology, machine learning, and biological engineering. Through Generative Biology and The Generate Platform, the company designs and optimizes proteins to create breakthrough medicines across multiple therapeutic modalities. Based in the United States, with facilities in Somerville, MA and Andover, the company emphasizes rapid, data-driven biotherapeutic development including antibodies, enzymes, and stealth proteins.
Recent News
STAT+: A Sign Biotech Is Back? Four Drugmakers Go Public, Raising Nearly $1 Billion in All
Bayer and Cradle Enter Collaboration to Enhance AI-Enabled Antibody Discovery and Optimization
Flagship's Generate:Biomedicines Files for IPO, Pitching AI-Driven Drugs
The IPO Buzz: Generate Biomedicines (GENB Proposed) Launches $400 Million IPO
Takeda, Iambic Partner in Latest Pharma AI Push